title: Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.
abstract: Rats (Sprague-Dawley), submitted to a mechanical noxious stimulus (paw pressure), were tested to determine 1) the antinociceptive effects of p.o. (200, 400 and 800 mg/kg), i.v. (50, 100, 200 and 300 mg/kg) and intrathecal (i.t.) (100 and 200 micrograms/rat) administrations of paracetamol; 2) the influence of i.t. administered tropisetron, a 5-hydroxytryptamine3 (5-HT3) receptor antagonist (0.5, 1 or 10 micrograms/rat) on paracetamol-induced antinociception; 3) the influence of indomethacin (25 mg/kg s.c.), naloxone (10 micrograms/rat i.t.) and yohimbine (1 mg/kg i.v.) on the effect of paracetamol (200 mg/kg i.v.) to determine the involvement of prostaglandins, opioids and alpha-2 adrenoceptors. The displacement by paracetamol of radioligand binding to various receptors was also investigated. Paracetamol induced a significant antinociceptive effect after p.o., i.v. and i.t. administration. A total inhibition of the effect of paracetamol, administered p.o. or i.t., occurred at the dose of 0.5 microgram/rat of tropisetron, whereas 10 micrograms/rat of this antagonist was needed to totally inhibit the action of i.v. administered paracetamol. Indomethacin, naloxone and yohimbine failed to modify paracetamol antinociceptive action. In vitro studies failed to show any binding of paracetamol to 5-HT3 and several other receptors and to 5-HT uptake sites. It is concluded that paracetamol has a central antinociceptive effect, based on an indirect involvement of spinal 5-HT3 receptors.
authors.affiliation: Equipe Neuro Psycho Pharmacologie Université d'Auvergne, Faculté de Médecine, Clermont-Ferrand, France.
authors.forename: T
authors.initials: T
authors.lastname: Pelissier
authors.forename: A
authors.initials: A
authors.lastname: Alloui
authors.forename: F
authors.initials: F
authors.lastname: Caussade
authors.forename: C
authors.initials: C
authors.lastname: Dubray
authors.forename: A
authors.initials: A
authors.lastname: Cloarec
authors.forename: J
authors.initials: J
authors.lastname: Lavarenne
authors.forename: A
authors.initials: A
authors.lastname: Eschalier
mesh_terms: D000082:Acetaminophen / Q000494:pharmacology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D010147:Pain Measurement; D011869:Radioligand Assay; D051381:Rats; D017207:Rats, Sprague-Dawley; D011985:Receptors, Serotonin / Q000187:drug effects*; D014828:Vocalization, Animal / Q000187:drug effects*
chemical_list: D011985:Receptors, Serotonin; D000082:Acetaminophen; D009270:Naloxone